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Executive Summary

Diabetes is one of the most serious public health problems of the twenty first century
(Albright, 2007; Glasgow et al., 1999). The rate of increase in the occurrence of diabetes and its
complications has placed a tremendous burden on the American health care system and threatens
to affect close to one third of the population in the next thirty years. Diabetes complications
markedly reduce the quality and length of life and contribute to enormous health care costs.
Several large studies have shown that effective treatments and practices may substantially reduce
the impact of diabetes (Herman, 2007).
Performance measures for diabetes have been in place since the late 1990s (Murphy,
Chapel, & Clary, 2004). There is evidence that control of outcome measures such as LDLcholesterol, blood pressure and HgbA1c have a positive impact on reducing the severity and
progression of diabetes. The systems change project was developed to pilot a facilitator model
for system change using evidence based quality measures to improve diabetes outcomes in a
small primary care clinic. Results of the project showed significant improvement in the effects of
clinicians (random effects) on diabetes outcome measures (fixed effects) for LDL-cholesterol (p
= 0.017), HgbA1c (p = 0.004), and tobacco nonuse (p = 0.0051). The change in percent
composite outcome measures for diabetes was also significant (p = 0.01). The hierarchical
generalized linear model was used to account for provider impact on patient outcomes. Response
to the facilitator model was generally positive as a means of promoting a quality improvement
initiative in diabetes, encouraging a multidisciplinary model of chronic disease management and
enhancing the use of organizational systems to plan and track patient care.
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The Effect of Practice Facilitation on Diabetes Registry Outcome Measures
Chapter 1
Background
Diabetes is a major public health problem with tremendous medical, economic, and
personal consequences. It is a chronic illness that affects people across the lifespan, and is one
of the most costly diseases to the United States (Glasgow et al., 1999; Narayan, Boyle,
Thompson, Sorenson, and Williamson, 2007). If not diagnosed and treated properly diabetes can
lead to serious complications such as heart disease, stroke, blindness, lower-limb amputations,
kidney failure, disability and premature death.
Rising Prevalence
Diabetes is a chronic and devastating disease that now affects 8.3% of the United States
(U.S.) population, and 11.3% of Americans over the age of twenty (American Diabetes
Association, 2011). Diabetes is the seventh leading cause of death in the U.S. (Centers for
Disease Control and Prevention, 2012). The number of new cases of diabetes diagnosed each
year began to increase in 1992. From 1990 to 2010 the incidence of diabetes in the US nearly
tripled. The prevalence of diabetes in the United States also remained constant until the early
1990s. Between 1990 and 2010, the prevalence of diabetes nearly quadrupled (Centers for
Disease Control and Prevention, 2012). If current trends continue, the Centers for Disease
Control and Prevention projects that by 2050, one in three adults in the US will have diabetes, an
increase of more than 163% (Boyle, Thompson, Gregg, Barker, & Williamson, 2010; Centers for
Disease Control and Prevention, 2012).
The development of diabetes is strongly linked with aging, obesity, and the increasing
racial and ethnic diversification of the population (Centers for Disease Control and Prevention,
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2012). Sixteen percent of people over the age of 65 have diabetes as opposed to 2% of people
age 20 to 45 (Centers for Disease Control and Prevention, 2012). The prevalence of diabetes is
also higher among certain racial and ethnic groups such as Hispanics and Blacks, but is
increasing most rapidly among Native Americans (Agency for Healthcare Research and Quality,
2008).
Complications of Diabetes
Diabetes is now the seventh leading cause of death in the United States (Centers for
Disease Control and Prevention, 2012). People with diabetes are at great risk for serious and lifethreatening complications. Adults with diabetes have a two to four fold greater chance of
developing heart disease or having a stroke (National Diabetes Information Clearinghouse,
2012). Small blood vessel changes in diabetes lead to an increased risk of eye, kidney and nerve
disease. Diabetes is the leading cause of adult kidney failure and a major contributor to adult
blindness (Centers for Disease Control and Prevention, 2012). The combination of circulatory
and nerve disease leads to an increased occurrence of lower-limb amputations (American
Diabetes Association, 2011). People with diabetes can, over time, develop nerve damage
throughout their body which can lead to chronic pain, immobility, and long-term disability
(National Committee for Quality Assurance, 2012). The long prodromal phase before diabetes is
diagnosed results in a high rate of complications that are already present at the time the diagnosis
is made (Deshpande, Harris-Hayes, & Schootman, 2008).
Poorly controlled diabetes before conception and during pregnancy can cause major birth
defects, spontaneous abortions, and excessively large babies posing a risk to mother and child
(Centers for Disease Control and Prevention, 2012). Uncontrolled blood sugar during pregnancy
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has been associated with an increased risk of metabolic syndrome and diabetes in the offspring
(Boney, Verma, Tucker, & Vohr, 2005).
The High Cost of Diabetes
The costs associated with diabetes are staggering. The average medical expenditures
among people with diagnosed diabetes are 2.3 times higher than for people without diabetes
(American Diabetes Association, 2011). Data released by the Centers for Disease Control in
2007 show that the total cost of diagnosed diabetes in the United States was $174 billion. This
amount included $116 billion of direct medical costs and $58 billion of indirect costs from
disability, work loss and premature death (Centers for Disease Control and Prevention, 2011;
Gilmer et al., 2005). A sampling of 10 million commercial health plan members, showed that the
average annual costs incurred by a patient with diabetes in 2009 was $11,700 compared with the
annual costs of $440 for a patient without diabetes. The average annual cost incurred by a
diabetic patient with complications was $20,700, nearly three times that of a diabetic patient
without complications (United Health Center for Health Reform & Modernization, 2010).
The current approach to diabetes care is projected to see annual costs (in 2012 dollars)
rise from $156 billion in 2010 to $192 billion by 2020 with direct medical costs increasing to
$138 billion and indirect costs from lost productivity increasing to $54 billion (U.S. Department
of Health and Human Services, 2004; Winterfeld, 2009). By some estimates, there is a real
possibility that diabetes will bankrupt the healthcare system (American Association of Clinical
Endocrinologists, 2011).
Disparities in Health Care
The greatest burden of diabetes falls on racial and ethnic minorities (Prina, 2010; Sequist
et al., 2008; White, Beech, & Miller, 2009) There is considerable evidence that the social status
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of persons with diabetes and the characteristics of their communities or neighborhoods may
determine their risk of mortality and diabetes-related complications (Brown et al., 2004; White et
al. 2009). The National Health Interview Surveys documented lower educational attainment,
higher unemployment, and lower family income among Americans who reported having diabetes
(Mann, Ponieman, Leventhal, & Halm, 2009; Sequist et al., 2008). A study conducted by White
et al. (2009) found that more than half of low-income minorities with diabetes held major
misconceptions about diabetes and its management that significantly and negatively impacted
disease treatment outcomes.
Among Hispanics, the fastest growing minority population in the U.S., the prevalence of
diabetes is two times that of non-Hispanic Whites (Braverman, Cubbin, Egerter, Williams &
Pamuk, 2010; Centers for Disease Control and Prevention, 2001) and increases significantly for
those with less than a high school education (Brown et al., 2011). The lifetime risk for
developing diabetes is greater among Hispanics than any other ethnic groups (Centers for
Disease Control and Complications, 2011). Between 1990 and 1998 the number of American
Indians and Alaska Natives with diabetes increased 71% (Agency for Healthcare Research and
Quality, 2008). Rates of diabetes related deaths is higher among Blacks, American Indians, and
Hispanics than for Whites (Centers for Disease Control and Prevention, 2012), and diabetes is
the fifth leading cause of death for Asian and Pacific Islanders (National Diabetes Information
Clearinghouse, 2012).
Certain minority groups also have much higher rates of diabetes related complications, in
some cases as much as 50% more than the diabetes population as a whole (Hale et al., 2010).
Blacks, especially, are more likely to have serious complications from diabetes, such as end
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stage renal disease and lower extremity amputations (Agency for Healthcare Research and
Quality, 2001; White et al., 2009).
Effectiveness of Interventions
Diabetes has a tremendous impact on health spending and quality of life for those
affected by the disease. Yet type 2 diabetes, the most common form, can be prevented and
controlled. Research findings indicate that diabetes prevention and management works (Albright,
2010; Hale et al., 2010; Nguyen, Nguyen, & Felicetta, 2008). The Diabetes Prevention Program
showed a 58% reduction in the onset of diabetes over a three year period through the use of diet
and exercise alone (National Diabetes Information Clearing House, 2011). Studies in China and
Finland have had similar results (Pan et al., 1997; Tuomilehto et al., 2001). Findings from The
Diabetes Control and Complications Trial; The United Kingdom Prospective Diabetes Study
Group; and the Action to Control Cardiovascular Risk in Diabetes Trial show that with the
proper treatment and glucose control, complications can be minimized (National Institutes of
Health, 1993; National Institutes of Health, 2008; Turner, Cull, & Holman, 1996). State diabetes
prevention and control programs, funded partially by the Centers for Disease Control and
Prevention, have been associated with noticeable improvements in diabetes prevention and
treatment (Centers for Disease Control and Prevention, 2011). Successful prevention and
management of diabetes can decrease the high cost of care and improve the quality of life for all
people affected by the disease.
Return on Investment
Public health experts agree that investing in diabetes prevention and control efforts can
improve health outcomes across populations and reduce health care costs nationally (Agency for
Healthcare Research and Quality, 2008; Albright, 2010). Cost analysis of the Diabetes
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Complication and Control Trial showed that even at two to three times the expense of
conventional therapy, the lifetime costs of improved care were offset by the lifetime costs of endstage renal disease, blindness and lower-limb amputations (Diabetes Control And Complications
Trial, 1996; Herman & Eastman, 1998). Sidorov et al. (2002) determined that comprehensive
care for diabetes in a managed care program resulted in per month claims of $394.62 for
enrollees in the program versus per month claims of $502.48 for those with diabetes not enrolled
in the program. Beaulieu et al. (2006) estimated the cumulative discount in net savings to the
health plan for patients enrolled in a diabetes program for 10 years was $5,345 per diabetic
member. Nuckols et al. (2011) found that the cost of care for improved diabetes control was
$830.39 annually as opposed to $503.38 annually for those with status quo care, but calculated
the cost effectiveness ratio to be $44,869/quality adjusted life year (U.S. dollars for 2009) for
those with good diabetes control as defined by HgbA1C <8%.
A growing body of research indicates that payers, patients, and society in general can see
a long-term return on investment in diabetes quality improvement (Klonoff & Schwartz, 2008;
Krause, 2005). Cost savings are difficult to calculate accurately because of the large number of
individuals who have diabetes and have yet to be diagnosed, and those who have diabetes but
have not sought treatment. Additionally, evidence points to the fact that the real cost savings for
diabetes occur far in the future, and are even more difficult to accurately quantify. Research
shows that improved care makes a significant difference on all levels.
Healthcare Mandate
The American health care system has difficulty routinely and consistently translating
research into practice, adhering to guidelines for proper care, and improving health care
outcomes (McGlynn et al., 2003). These difficulties are particularly true for diabetes care. It is
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estimated that 50% of people with diabetes are as yet, undiagnosed (International Diabetes
Federation, 2010). Others who are diagnosed lack adequate treatment and do not know how to
manage their disease well over time (Agency for Healthcare Quality Improvement, 2008).
A 2006 survey of diabetes care based on data from the National Health and Nutrition
Examination Survey and the Behavioral Risk Factor Surveillance System found that only 42% of
individuals with diabetes had glycosylated hemoglobin (HgbA1c) levels less than 7% (optimal
control), a number that has not substantially changed since 1998 (Agency for Healthcare Quality
Improvement, 2008). In Minnesota the statewide rate for optimal diabetes control at the clinic
level in 2010 was 37% (Minnesota Community Measurement, 2011).
Legal and Political Mandate
The U.S. government has in the last several years, taken a more active role in a range of
programs and initiatives to decrease the impact of diabetes. There is an imperative to extend that
engagement to all levels of the health system and all sectors of government and the public to
address determinants of disease and transform the system from one of sickness to one of health
promotion (O'Connor, 2012; Kahn, 2009). In 2007, the National Council on Development
Planning commissioned Mathematica Policy Research, Inc. (Novo Nordisk, 2012) to identify the
range and kinds of federal programs, authority, and funding that would influence the incidence,
prevalence, treatment, and progression of diabetes. The results show there was a lack of
effective, coordinated federal leadership and spending in diabetes prevention, treatment, and
care. Yauch, Hawkes, Linn, Gould, and Galbraith (2004) identified three strategies for change: 1)
raising the profile of chronic disease in the minds and on the agenda of policy makers; 2)
providing policy makers with the necessary evidence to support the case for prevention; and 3)
advocating the need for widespread health system changes.
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Determinants of Health and Social Justice
In the U.S. today, the single largest cause of poor health outcomes is chronic disease
(Centers for Disease Control and Prevention, 2012). Evidence now indicates that the most
powerful predictor of whether a person will develop a chronic disease is their socioeconomic
status (Bell et al., 2010; Braverman et al.; Sequist et al., 2008; White et al., 2009). The
socioeconomic factor is because higher income increases the probability that people can and will
choose healthier food and activity levels. Research shows that individuals with higher incomes
suffer less from chronic stress which interacts with the immune and neurological system to set up
risk factors for many chronic diseases.
Larger social systems that support and surround the individual are influenced by and in
turn influence, the individual both positively and negatively. Management of diabetes occurs
largely in outpatient settings and most often in primary care clinics. Sequist et al. (2008) found
that patient sociodemographic factors explained 13% to 38% of the racial differences in
improving diabetes outcome measures. Unfavorable social conditions and ineffective selfmanagement often have a greater impact on health outcomes than planned interventions from
medical providers. In such a context, the most important determinants of health are the patients
and their interactions with the environment around them. It is essential to look beyond the care of
the individual patient to the health of the larger community with attention to equity and the most
efficient use of resources in ways that enhance patient and community quality of life.
Quality improvement in diabetes is really about equity in health care delivery. Health
disparities produce avoidable suffering, diminish human resources, and decrease productivity on
many levels. They deny equal opportunity for health and quality of life. Horizontal equity refers
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to the equal treatment for individuals or groups with the same or similar levels of health care
need (Ward, 2009). Horizontal equity is an essential component of quality chronic disease care.
The doctor of nursing practice curriculum and the system change project is rooted in the
imperative to seek out inequities within the system, and create a vehicle for change that can be
self-sustaining and transformative. Such an opportunity occurs with this diabetes project. As a
result of the intervention, providers express greater confidence, satisfaction, and success in their
ability to care for their diabetes patients, build productive relationships with their patients, and
provider teams, and meet organizational expectations. Patients generally are able to see
improvement in their diabetes outcomes and consequently have the opportunity to decrease
complications and improve their quality of life. Most importantly, care is distributed equally
without regard to the individual’s race or ethnicity. There are three domains of equity within
healthcare: equal access to health care for people in equal need; equal treatment for people in
equal need; and equal outcomes for people in equal need (Ward, 2009). Issues of access are only
marginally addressed by process and outcome measures for quality improvement. Improvement
in quality of care more directly applies to treatment, and outcomes.
The diabetes management regime is among the most demanding regimes of any chronic
illness and is based on a number of lifestyle changes that people with diabetes often find difficult
to incorporate into their everyday lives. Improving care delivery is essential to developing a
more supportive and optimal environment for long term chronic disease management (Averbeck
et al., 2009).

PRACTICE FACILITATION

18
Practice Facilitation

According to Baskerville, Liddy, & Hogg (2012), practice facilitation is a multifaceted
approach that involves skilled individuals who enable others through a range of intervention
components and approaches to address the challenges in implementing evidence-based care
guidelines within the primary care setting. Facilitators are individuals with recognized skills in
an identified area of health care and who are perceived as credible implementers of change. The
role does not impose ways of working on individuals, is neither prescriptive nor directive, but
strives to help people recognize and attain their greatest potential. Facilitation has been
increasingly used in Europe and Canada since the early 1980s, but is a relatively new concept in
the U.S.
The facilitation process itself is by nature both fluid and organized in that clear practice
guidelines are the basis for the needed change, but introduction and adaptation to the individual
and the context are essential to the successful incorporation of the new methods of operation. As
such, a diversity of approaches in moving evidence into practice reflects the multifaceted nature
of facilitation. Important roles for the facilitator are to promote awareness for the need for
change, provide leadership and management of the change process, encourage relationship
building and communication, and provide ongoing mentoring, monitoring, and evaluation.
Several elements of the facilitation process were attractive for the systems change
project. Essential components of facilitation were the process of individual and group interaction
that was the basis for improved understanding, problem solving, and incorporation of new
patterns into daily clinic practice. The opportunity to tailor the facilitation to the local context
and to provide individual support and encouragement through the change process offered a
unique opportunity to implement theory from both nursing, health care, and business sectors.
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Organizational Background

Health care organizations and individual healthcare providers have been under increased
pressure to improve treatment outcomes, especially in the area of chronic disease management.
The Diabetes Quality Improvement Project founded in 1997 through a partnership between the
Center for Medicare and Medicaid Services, the National Committee for Quality Assurance, and
the American Diabetes Association, established a single, standardized set of performance
measures for diabetes care quality improvement and accountability in the U.S. Changes in the
healthcare system to promote improved outcomes were given impetus by the Institute of
Medicine report in 2001 that called for providing physicians with more financial incentives for
quality improvement (Institute of Medicine, 2001). Further changes thorough the Affordable
Care Act of 2010 at the national and state level have increased the surveillance for diabetes and
strengthened the mandate for healthcare organizations to adopt comprehensive programs to
improve outcome measures. The development of diabetes registries that track outcomes for
patients with diabetes have been an important part of this process. The result of these activities is
that local healthcare organizations are strongly encouraged to follow federal guidelines to ensure
compliance, reimbursement and better patient outcomes.
This project took place in a multispecialty primary care clinic that is part of a large
organization located in the Midwest, U.S. The larger organization is a non-profit institution that
primarily serves an urban population. The mission and vision of the larger organization are to
serve the community by providing exceptional care, preventing illness, restoring health, and
providing comfort to all members. The organization’s vision is to put the patient first and lead
collaborative efforts that solve the community’s health care challenges.
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In 2009, a small, multidisciplinary practice comprised of eight medical clinics and four
urgent care centers in the Twin City area was absorbed into the much larger healthcare
organization that was composed of over one hundred clinics and urgent care centers and ten
hospitals throughout the state of Minnesota. The larger system was a recipient of the American
Medical Group Foundation’s 2008 Acclaim Award for its initiative around optimal diabetes care
(Sanderson-Austin, Branning, Bauwens, & Smith, 2009). It also was a two-time recipient of the
Minnesota Bridges to Excellence Award (2008 & 2011) for exceptional diabetes care. A stated
goal of the larger healthcare organization was to extend the diabetes care initiative activities to
include the newly acquired practice.
Organizational Structure
Within the context of these national and organizational mandates, one small healthcare
system became the focus of a systems change project to facilitate improved diabetes
management outcomes. This clinic is part of the smaller system that was absorbed into the much
larger organization. Practice context differed greatly between the smaller system and larger
organization. The small, primary care clinic consists of nine internal medicine and family
practice physicians, two primary care nurse practitioners, and eleven clinical assistants. The first
language of four of the physicians is not English and they received their medical training outside
the United States. The clinic is located in the second largest county in the state and serves a
largely suburban population. The county is in the lowest one third of the state’s health status
morbidity and mortality rankings and lowest one third of the state’s social and economic factors
rankings (Robert Woods Johnson & University of Wisconsin, 2011). Two thirds of the county
population is white with the remaining one third consisting primarily of Black and Asian
residents. A small percentage of Hispanic and Latino families are served by the clinic. Nearly
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16% of the population has an income that is below the poverty level (GeoLytics, 2011). The
prevalence of diabetes in this county in 2009 was 7.2% (Centers for Disease Control and
Prevention, 2011). The number of patients with diabetes on each physician’s registry ranged
from 16-106 with four of the six physicians having more than 50 patients on their registry.
Providers’ Expectations
Patients with diabetes in the smaller system were added to the organization-wide diabetes
registry and all providers in the smaller system were given year-end diabetes outcome targets to
achieve for their panel of patients. Outcome targets were based on Minnesota Community
Measures evidence-based guidelines with a year-end goal of 38% percent achievement
established by the parent organization.
This initiative produced considerable confusion on the part of providers in the smaller
system as there was limited communication about the rationale for the initiative and the choice of
outcome measures utilized. Additionally, there was no organized diabetes program in the smaller
system, nor was there a program in place to educate and support the physicians who sought to
improve diabetes outcomes for their patients. There was also a clear understanding
communicated to all physicians that financial remuneration, and perhaps job security, was
connected to success in meeting outcome goals.
Problem Statement
Monthly diabetes outcome reports and adherence to recognized standards or outcome
measures have been linked to job performance reviews and incentive pay for providers.
Individual providers have been under increased pressure to change practice patterns to achieve
outcome goals for all their patients. Demands of a busy practice, limited reimbursement for
services, shorter time for patient visits and a constantly changing understanding of diabetes and
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treatment options make it extremely difficult for the primary care provider to deliver quality
care.
The systems change project was conceived out of the realization that providers in a small
primary care clinic needed assistance to incorporate evidence based guidelines into their practice
and gain confidence in caring for their patients with diabetes. At the same time, consumers
needed to receive a level of care for their diabetes that met expected standards of care based on
current evidence.
Problem Purpose
The purpose of the project was to deliver practice facilitation intervention to improve
primary care providers’ comfort and improve diabetes quality of care within their primary care
clinic.
Research Question
Does practice facilitation improve provider’s comfort with adult diabetes care delivery
and improve diabetes outcome quality measures?
Project Overview
Six primary care providers and their clinical assistants (provider teams) were coached on
a one-to-one basis in the utilization of evidence based guidelines for the delivery of care to their
patients with diabetes. A practice facilitation model incorporating a nurse practitioner diabetes
specialist with volunteer participants was implemented for a period of four months. The
organizational diabetes registry was used to follow patients and adjust treatment. Diabetes
outcome measures (LDL-cholesterol, blood pressure, glycosylated hemoglobin, tobacco nonuse
and aspirin use) as well as composite measures of all five outcome measures were monitored
monthly to determine the effectiveness of the practice changes. This project also met the stated
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organizational goals to have all providers improve the quality of diabetes care in their individual
practices.
Project Objectives
The objectives of this project were to evaluate the effectiveness of a practice facilitation
coaching for providers and provider teams and to incorporate evidence-based guidelines into
clinical practice for improved diabetes care. Outcome measures and monthly composite
measures were used as indicators of improved care
Project Aims
1) To improve diabetes composite measures to a target of 38% by the completion of the
project
2) To increase providers’ knowledge and confidence in caring for their patients with
diabetes.
3) To improve health team processes for the delivery of evidenced based care to their
patients with diabetes by more consistent use of diabetes registry data.
Definition of Terms
BP

Blood pressure

Composite measures

Bundling of measures for a specific condition to determine
if all critical aspects of care have been achieved

HgbA1c

Glycosylated hemoglobin, the average blood glucose level
for the preceding three month period, expressed in a
percent.

LDL (cholesterol)

Low density lipoprotein cholesterol, independent risk factor
for heart disease

Outcome measures

Management goals for specific diseases that have been
established by consensus as targets for quality care and
reflect how the patient’s health has improved.

PRACTICE FACILITATION
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Health professional who assists clinicians in research and
quality improvement projects.

Process measures

Actions taken by a provider to improve the quality of care
such as ordering tests, making referrals and performing
examinations

Provider

Health care professional (physician, nurse practitioner,
physician assistant or doctor of osteopathy) who directs and
manages the health care for an individual patient

Provider team

A group of health professionals consisting of the provider,
nurse and/or clinical assistant who work together to deliver
care for an individual patient
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Chapter 2
Theoretical Framework
The systems change project incorporates three theoretical frameworks: the
science of unitary human beings theory by Martha E Rogers, the eight stage process for systems
change by John Kotter, and the chronic care model developed by Group Health’s MacColl
Institute for Healthcare Innovation. Elements from each theory have direct application to the
issues confronted by the project, and more particularly, to challenges inherent in working with
individuals who are the providers and consumers of healthcare.
Martha Rogers' Science of Unitary Human Beings
Martha Rogers first published her theory in An Introduction to the Theoretical Basis of
Nursing, (1970). Her work was in response to the need to establish nursing as a science and
postulate a set of principles that would direct nurses’ thinking and activity (Butcher & Maliski,
2010). Her work derived from extensive reading in the behavioral and physical sciences and her
experience as a public health nurse and educator (Phillips, 2010). Rogers’ theory has had a
profound impact on nursing practice, research, and education as it articulated a model for nursing
distinct from the traditional medical model, and more inclusive of an open-system world view
(Butcher & Malinski, 2010; Wright, 2007). Her science was rooted in a unitary consciousness
paradigm that proposed energy fields as the fundamental unit of the living and nonliving
(Watson & Smith, 2002; Wright, 2006). Humans are described as unitary and irreducible, and in
harmonic interaction with the environment. As such, humans and the environment interact in a
dynamic, infinite, and continuous manner. Rogers’ postulates of energy fields, openness, and
patterning (recognition through familiar patterns that are greater than the sum of their parts),
were underscored by a pandimensionality that identified life processes existing along an
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irreversible space and time continuum yet without any spatial or temporal attributes (Klemm &
Stashinko, 1997; Phillips, 2010; Watson & Smith, 2002). Rogers used the term homeodynamics
to describe the dynamic, ever-changing nature of life and the world. She further identified three
concepts associated with pattern manifestation. Resonancy was the term used to describe change
that occurred in a nonlinear, continuous flow of higher and lower light frequency wave patterns.
Heliacy described the creative, diverse nature of ongoing change, and integrality was the context
in which change occurred, namely the mutual, inseparable human-environment field process
(Phillips, 2010; Watson & Smith, 2002).
The expanded world view in Rogers’ theory focuses attention on human life as a process
of dynamic change that is unpredictable, creative, evolutionary, and continuous. Humans within
this system are unique, whole, and greater than the sum of their parts, and in perpetual, reciprocal
interaction with their environments. Rogers’ system is acausal since it has no boundaries and is
in constant change (Barrett, 2010; Phillips, 2010). Humans and the environment interact
continuously, creating new patterns, and participating in an irreducible wholeness. Nursing’s
goal then is to see these individuals within their environment, embrace the mutual process of
interaction between the individual and the environment, and work to establish strategies and
patterns that will promote health and well-being. Rogers’ model has application to all areas of
health care practice and strongly influences response to change within a system. Change is
continuous and must be accepted as a reality in all aspects of human interaction.
Explicit assumptions in her model are focused on the unity of the individual, continuous
reciprocal interaction with the environment, the dynamic evolution of existence, the capacity to
influence patterns, and the worthiness of the process. Implicit in Rogers’ theory is the value and
uniqueness of each individual and nursing’s potential to contribute and engage in the process.
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Effective engagement is predicated on the acceptance of unceasing change, and the uniqueness,
and reciprocity between the individual and environment.
Kotter's Eight Stage Process Model
John Kotter, a Harvard Business School professor and graduate of Massachusetts Institute
of Technology, has written extensively on change in organizations. His basic thesis, like Martha
Rogers, is that change is constant. His model is based on research and direct observation of
organizations around the world. He acknowledges a paradigm shift in organizations since the
1960s from a focus on stability and predictability to one of continuous change and innovation
(Kotter, 1996). He attributes the need for change to the major economic and social forces that
have resulted in a globalization of both markets and competition. He identifies two important
factors for successful change. The first is a multistep process that creates motivation and power
which will counter the inertia within the organization. The second is the use of highly effective
leadership that will establish direction, align people as change agents, and motivate and inspire
people to overcome obstacles associated with the change process (Kotter, 1996).
Kotter’s eight-stage process (Table 1) is detailed and sequenced, with emphasis on the
importance of completing each step before advancing to the next. The theory presents a view of
the twenty-first century organization that is less bureaucratic than streamlined, externally
oriented, and risk tolerant. He advocates for a more open, candid, and empowering environment
for employees. The theory maintains that successful transformation is largely the result of strong
leadership and only marginally associated with good management (Kotter, 1996). He clearly
defines what is meant by leadership, and argues convincingly that management is a less essential
component of successful change because it is too isolated and removed from vision formation.
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Table I
Kotter’s Eight Stage Process Model

Stage
Stage One

Stage Two

Goal

Activity

Create urgency

Develop a sense of urgency around the

for change

need that will spark the initial motivation

Form a powerful

Bring together a team of influential people

coalition

with power from a variety of sources who
will support the change process

Stage Three

Create a vision

Develop a brief summary of values behind

for change

the change and strategy for implementation
for change that are clear and easy to
remember

Stage Four

Communicate the

Talk about the vision openly, honestly,

vision

daily and apply to all aspects of the
operation

Stage Five

Remove obstacles Develop and activate the structure for
change and act to remove barriers to its
development

Stage Six

Stage Seven

Create short-term

Create small, achievable targets that can

wins

motivate with results

Build on change

Build on what went right and identify how
to improve by setting new goals

Stage Eight

Anchor the

Incorporate changes into every aspect of

changes in

the organization

corporate culture
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The Chronic Care Model
The chronic care model identifies the essential elements of a health care system that
encourages high-quality chronic disease care. These elements are the community, the health
system, self-management support, delivery system design, decision support, and clinical
information systems. In combination, evidence-based change concepts under each element
facilitate productive interactions between informed patients and providers with resources and
expertise. Patients are at the center of the health care plan and take an active part in their care
(Group Health's MacColl Institute for Healthcare Innovation, RAND, & California Health Care
Safety Net Institute, 2008). One of the major problems addressed by the chronic care model is
the fact that current care of chronic illness is often reactive and triggered by actual problems
instead of being proactive, structured, and planned.
Application to Systems Change Project
Rogers’ theory directs attention to the essential role of each individual (both providers
and consumers of health care) and the dynamic, complex, and reciprocal nature of interactions
between individuals and their environments. Her theory supports principles of social justice and
health equity by ensuring respect for all persons and imbedding change within the context of
each individual’s life circumstance whether that be personal or professional. Kotter’s eight stages
are a tool to formulate a plan for identifying the needed change, building support for the change,
and moving from beginning to end of the change process. His focus on leadership further
supports the facilitator role. The chronic care model outlines specific components of ongoing
chronic disease care that once again place the individual patient is at the center of the care
process. The chronic care model incorporates the range of environments and organizational
systems that are essential components of successful disease management and health promotion.
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These theories and models support patient centered care and empower providers and consumers
of health care to be collaborative in their efforts to improve the quality of their care.
Literature Review
Measuring Quality in Diabetes Care
A great deal of progress has been made in the United States and Europe during the last
fifteen years in the development, specification, and field-testing of measures for diabetes care
(Nicolucci, Greenfield, & Mattke, 2006). Much of the work on standardized measures for quality
care began in the U.S. with the formation of the Diabetes Quality Improvement Program which
was a physician driven program (McLaughlin, 2000). The Diabetes Quality Improvement
Program evolved into the National Diabetes Quality Improvement Alliance which is composed
of national organizations that are concerned about the care of patients with diabetes (Agency for
Healthcare Research and Quality, 2008).
In clinical practice, two terms “standards of care” and “outcome measures”, are used
frequently. It is important to note the distinction between these two terms. The standards of care
for diabetes serve to provide health professionals, patients, researchers, payers, and other
interested individuals with the components of diabetes care, treatment goals, and tools to
evaluate quality of care (American Diabetes Association, 2012). Outcome measures are an
indicator or tool used to assess the level of care provided within a system of care to populations
of patients with diabetes (McLaughlin, 2000). Outcome measures do not reflect either the
minimal or maximal level of care that should be provided. Measures do, however, serve as a
consistent tool across health care systems to demonstrate the quality of care provided to its
members. Outcome measures are evidence-based, derived from standards of care and positions
statements from professional organizations, and agreed upon by panels of experts in the field of
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diabetes care, research, education, data collection, medical reimbursement, and quality
improvement (Agency for Healthcare Research and Quality, 2008).
In 2007, the American College of Physicians published an article in which the Appraisal
of Guidelines for Research & Evaluation (AGREE) instrument was applied to nine sets of
diabetes practice guidelines (Qaseem et al., 2007). Of the nine guidelines, four (National Institute
for Health and Clinical Excellence, Scottish Intercollegiate Guidelines Network, Veterans Health
Administration and Canadian Diabetes Association) achieved the highest score. However, a
review of the literature indicates that in addition to the National Institute for Health and Clinical
Excellence guidelines, three other guidelines (American Association of Clinical
Endocrinologists, American Diabetes Association, and Institute for Clinical Systems
Improvement) now serve as a basis for the formulation of outcome measures in Minnesota
(Minnesota Community Measures, 2008). It is important to note that the National Institute for
Health and Clinical Excellence, the Institute for Clinical Systems Improvement, and as of 2012,
the American Diabetes Association guidelines emphasize that glycemic control should be
individualized for each patient. Glycemic control is especially important when tailoring
treatment plans to individual patient’s health care needs and concerns, but become problematic
when outcome measures do not accommodate such flexibility.
Criteria for the development of quality performance outcome measures differ from
clinical practice guidelines in that feasibility and variability are important considerations.
Feasibility relates to whether the measure can be collected accurately, reliably, and at reasonable
cost (Nicolucci et al., 2006). Variability relates to standardization of the measure across multiple
health care settings (Nicolucci et al., 2006). All measures use the number of clinically diagnosed
diabetic patients as their denominator. Diagnosed patients who have not been tested are
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considered to have failed the standard. Missing data is similarly considered to be a failure. Great
Britain, Canada, and the United States all have similar outcome measures that include A1c, and
LDL-cholesterol levels (Klomp, Dyck, Cascagnette, & Teare, 2010; Si, Bailie, Wang, &
Weeramanthri, 2010). Great Britain and Canada include annual screening for nephropathy and
eye examination (Si et al., 2010). In the United States glycemic, lipid, and blood pressure control
are the major areas of concern for most organizations (Ahmann, 2007, BioMed Central Health
Services Research (2010).
Types of Quality Measures
Improving the quality of health care is dependent on the collection and analysis of data.
The Agency for Healthcare Research and Quality defines data as “values or estimates generated
to describe a concept and track it over time, space, and populations” (Agency for Healthcare
Research and Quality, 2008, Module 2, p. 2). Data provides a means of identifying quality
problems in healthcare, selecting possible solutions or interventions, evaluating the results of
selected interventions, and tracking those results over time. Data can also be used to compare
healthcare quality in different regions of the country or different health care systems within a
region. The healthcare quality measures used at the national and state level for quality
improvement relate to populations. The measures are often rates such as percentages that indicate
the number achieving a goal relative to a population base.
Most quality improvement efforts focus on process and outcome measures. Process
measures are based on disease specific guidelines of care. Process measures are those actions
taken by a healthcare provider to improve the quality of care such as the type of tests ordered,
referrals made or exams performed (Agency for Healthcare Research And Quality, 2008) . Since
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process measures are dependent on provider orders and actions they are often considered as
performance indicators.
The National Healthcare Quality Report process measures for diabetes are (Coffey,
Matthews, & McDermott, 2008):
•

HgbA1c test-Percent of adults with diabetes who had a hemoglobin A1c
measurement in the past year

•

Lipid profile-Percent of adults with diabetes who had a lipid profile in the past 2
years

•

Eye exam-Percent of adults with diabetes who had a retinal exam in the past year

•

Foot exam-Percent of adults with diabetes who had a foot examination in the past
year

•

Flu vaccination-Percent of adults with diabetes who received an influenza
immunization in the past year

Outcome measures refer to the patient’s health status or the results of specific treatment
recommendations. They are considered to be a marker of how much the patient’s health has
improved which is the ultimate objective of quality improvement efforts (Agency for Healthcare
Research and Quality, 2008).
The National Healthcare Quality Report outcome measures for diabetes are (Coffey et al.,
2008):
Test results
•

HgbA1c levels-Percent of adults with diagnosed diabetes with HgbA1c levels
>9.5% (poor control), <9.0% (needs improvement) and <7% (optimal control)

•

Cholesterol levels-percent of adults with diagnosed diabetes with most recent
LDL-cholesterol level >130 mg/dl (needs improvement) or <100 mg/per dl

•

Blood pressure-percent of adults with diagnosed diabetes with most recent blood
pressure <140/90
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Hospital admissions (per 1,000,000 population)
•

Hospital admissions for adults with uncomplicated, uncontrolled diabetes

•

Hospital admissions for adults with short-term complications of diabetes

•

Hospital admissions for adults with long-term complications of diabetes

•

Hospital admissions for lower extremity amputations for patients of all ages

Process measures have been criticized for having limited connection to actual clinical
outcomes (Nicolucci et al., 2006), and outcome measures have been criticized for not accounting
for factors that are beyond the provider’s control such as patient preference, regime
nonadherence, language barriers, etc. (Lovett & Liang, 2012). Composite measures are an
attempt to improve on the low statistical significance of process and outcome measures by
combining multiple measures in a single measurement (Lovett & Liang, 2012). In this way,
composite measures provide an overall summary of the quality of care delivered to a patient.
The Institute of Medicine defines composite measures as “the bundling of measures for a specific
condition to determine if all critical aspects of care… have been achieved for an individual
patient, thereby enhancing measurement to extend beyond tracking performance on separate
measures” (Institute of Medicine, 2006, p. 92). The American Medical Association supports the
use of composite scores in addition to individual outcome and process measures as a more
precise indicator of improvement that captures a spectrum of care (Physician Consortium for
Performance Improvement, 2010). Use of a variety of measures encourages clinicians to focus
on all aspects of care and facilitates more standardization for better interpretation of quality
assessment efforts. Advantages of composite measures are that they are easier to interpret for
consumers and fit well into a pay for performance program. Disadvantages are the difficulty in
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achieving consensus on composite design and scoring and the loss of important information if
the composite score combines unrelated metrics (Romano, Hussey, & Ritley, 2010).
Measuring Quality of Diabetes Care from State and Federal Perspectives
In the U.S., surveillance for diabetes care has changed focus from the use of Healthcare
Effectiveness Data and Information Set (HEDIS) which includes measures for glycemic control,
lipid control, blood pressure control, and medication for nephropathy (National Committee for
Quality Assurance, 2011) to the Institute for Clinical Systems Improvement recommendations
that glycemic control should be linked with cardiovascular risk reduction to include lipid and
blood pressure control, aspirin use, and tobacco cessation. In 2010, the Institute for Clinical
Systems Improvement guidelines were adjusted to target cardiovascular risk. Surveillance for
eye and kidney disease was discontinued (Institute for Clinical Systems Improvement, 2010).
On a state level, the Minnesota legislature adopted Minnesota Statute 62U.02 in 2009.
The statue required the Minnesota Department of Health to establish a standardized set of quality
measures for health care providers across the state for the purpose of producing an annual report
on health care quality (Minnesota Department of Health, 2011). The Minnesota Department of
Health contracted with Minnesota Community Measurement, a private corporation of health care
professionals, in collaboration with Minnesota Hospital Association, the Minnesota Medical
Association, the University of Minnesota, Stratis Health (the Medicare Quality Improvement
Organization for Minnesota), and many other community collaborators and health care
organizations to design, collect, and report new measures for diabetes care , vascular care, and
the patient experience of care (Minnesota Department of Health, 2011). The Minnesota
Department of Health adopted the first set of administrative rules (Minnesota Rules, Chapter
4654) establishing the Statewide Quality Reporting and Measurement System in December,
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2009. Physician clinics and hospitals were required to submit data needed to calculate applicable
quality measures and perform risk assessment starting January 1 2010. Minnesota Community
Measurement collected data submitted directly by physician clinics via a web-based portal
To meet their statutory requirements to risk adjust quality measures, the Minnesota
Department of Health developed a risk adjustment strategy in early 2010 for the first set of
physician clinic quality measures included in the Statewide Quality Reporting and Measurement
System. The University of Minnesota and Minnesota Community Measurement’s Measurement
and Reporting Committee reviewed the methodology in mid-2010. In developing the risk
adjustment strategy, the Minnesota Department of Health set out to collect data and report
quality measure results that were comparable across providers while minimizing the data
collection burden on providers. More comprehensive risk adjustment would have required
additional data elements be submitted by physician clinics. The more comprehensive adjustment
was considered too costly and cumbersome. The Minnesota Department of Health, the
University of Minnesota, and Minnesota Community Measurement continue to research and
investigate more robust risk adjustment options (Minnesota Department of Health, 2011). The
measures in the 2011 Health Care Quality Report for Minnesota were recommended and revised
over the years by Minnesota Community Measurement’s Measurement and Reporting
Committee, approved by their Board of Directors, and reflect current evidence-based guidelines
(MN Community Measurement, 2012).
Numerator components for optimal diabetes care measure specifications for 2012 are the
percentage of diabetes patients age 18-75 in the measurement period who meet the following
targets (MN Community Measurement, 2012).
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HgbA1c less than eight percent



Low density lipoprotein (LDL) cholesterol less than one hundred mg/dl



Blood pressure at or below 139/89



Tobacco nonuse



Daily aspirin use for those with documented ischemic vascular disease

These measures were agreed upon by all organizations participating in the Statewide
Quality Reporting and Measurement System, are referenced in the systems change organization’s
Diabetes Report, and are used to assess outcomes for each measurement parameter, and for the
percentage of patients achieving optimal outcomes in all parameters for the systems change
project.
Translating Research into Practice
Evidence based guidelines are not self-implementing (Green & Seifert, 2005). Changing
providers long-held patterns of behavior and the environments in which they work is complex
and difficult (de Belvis, Pelone, Biasco, Ricciardi, & Volpe, 2009; Willens, Cripps, Wilson,
Wolff, & Rothman, 2011). Unless barriers to change can be overcome and action taken to
improve compliance, efforts to develop evidence based guidelines are wasted.
A review of health care and social science literature reveals numerous studies that
document the limited success of traditional continuing medical education activities (Dancer &
Courtney, 2011; Kirkman, Williams, Caffrey, & Marrero, 2001). Case-based learning that aims
to incorporate evidence based guidelines to change clinical practice and improve disease
outcomes also produces limited long term change (Mold, Aspy, & Nagykaldi, 2008; Oxman,
Thomson, Davis, and Haynes, 1995). Learning alone, especially as a single event, is not
sufficient to change behavior and results in only modest improvement in outcomes (Lemelin,
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Hogg, and Baskerville, 2001; Pike, Indge, Leverton, Ford, and Gilbert, 2010; Sperl-Hillen et al.,
2010; Stolee et al., 2009). Audit and feedback systems for clinical management show only small
to moderate gains in successful chronic disease management (Jamtvedt, Young, Kristoffersen,
O'Brien, & Oxman, 2010). Brown et al. (2011) found that an integrated, web-enabled initiative
offered performance improvement and continued medical education as a unified entity for
diabetes management. However, most authors have documented particularly poor outcomes in
attempts to alter practice behaviors in diabetes and other chronic diseases. In studies where initial
practice changes to improve disease outcomes did occur, these changes were not sustained and
improved outcome measures did not continue (de Belvis et al., 2009; Kirkman et al., 2001;
Lemelin et al., 2001). Generalized guidelines for continuous quality improvement were also not
successful (Kottke & Solberg, 2001). Main, Curtis, Pitts, and Irish (2009) did have some success
with improvement in ongoing medical education through peer appraisal of learning, but did not
relate this to a change in practice behavior or clinical outcomes.
A systems approach with multifaceted learning was found to produce the greatest success
in changing provider behavior to incorporate evidence based practice and sustaining that change
(Renders et al., 2001). In addition, chronic disease markers tended to improve both for
intermediate and outcome measures (Damberg et al., 2010; de Belvis et al., 2009).
Organizational interventions with structured, regular review of patient outcomes had a positive
effect on processes of care (Renders et al., 2001). The most effective feedback was outcome
focused and occurred in real time (Doran & Sidani, 2007).
Change in Organizations
Factors that produced the sustained changes in clinical practice and resulted in improved
quality markers occurred when the organizational culture identified and supported the change
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(Pike et al., 2010; Renders et al., 2001; Sperl-Hillen et al., 2010). Such cultures exhibited strong
leadership to champion and support change, created an environment that supported individuals
through the change process, developed opportunities for teamwork and interaction, addressed
participants attitudes about the change, and tailored the change to each site (Fox, Swanson,
Kahn, Glaser & Murray; 2008, Ilag et al., 2003; Mathers, Maso, Heyrman & Gaspar, 2007;
Ploeg, Davies, Edwards, Gifford, and Miller, 2007; Solberg, Klevan & Asche, 2007).
Interventions that utilized a multicomponent strategy, with a variety of methods that introduced
process changes, and incorporated clinical practice guidelines were more successful (Benjamin,
Schneider & Hinchey, 1999; Dancer & Courtney, 2011, Mold et al., 2008; Oxman et al., 1995).
Damberg et al. (2010) found a positive correlation between large practice organizations size and
performance on technical quality and patient experience. Fish, Munro, and Bairstow (2009)
found that change occurred more readily when individuals were not completely free to choose
their part in the change process and when standards of performance were connected to features
of people’s tasks, tools, and operating environments. In addition to system components, SperlHillen et al. (2010) found that improvement in diabetes measures was tied to early drug
intensification, an increase in continuity of care, participation in diabetes quality initiatives, and
the use of multidisciplinary resources.
Practice Facilitation
Much of the literature on the incorporation of evidence based guidelines into clinical
practice refer to the use of facilitation and practice facilitators as an important feature of a
multicomponent intervention. Clinically based personnel, most often nurses, were seen as
essential players in the implementation and perpetuation of practice changes. When supported by
nursing and additional clinical staff, practice changes were more successful (Baskerville et al.,
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2012; Doran & Sidani, 2007; Jaen et al., 2009; Kottke & Solberg, 2001; Lemelin et al., 2001,
Margolis et al., 2004; McAllister & Osborne, 2006; Mold et al., 2008; Pike et al., 2010; Renders
et al., 2001). Physicians alone were found to implement guidelines only one third of the time,
despite computerized reminders (Willens et al., 2011). In one study looking at diabetes processes
in clinical practice, the only practices that continued, foot care and blood pressure measures,
were those done by nurses (Friling et al., 2002; Kirkman et al., 2001).
A model proposed by Kitson, Harvey, and McCormack (1998) utilized a system of
practice facilitation to assist providers to implement new guidelines into daily practice. She
defined facilitation as a technique by which one person “makes things easier” for others (Kitson
et al., 1998). Building on Kitson’s conceptual framework, Stetler et al. (2006) further expanded
the definition to include a deliberate and valued process of interactive problem solving and
support that occurs in the context of a recognized need for improvement, and a supportive
interpersonal relationship.
The practice facilitator role has been utilized in Europe since the early 1980s (Telligen,
2012), but is a relatively new concept in the American health system. In the U.S., the role
evolved from the Department of Agriculture’s use of agriculture experts who visited farms to
assist the farmers’ to incorporate best practices into their daily work (Grumbach, Bainbridge, &
Bodenheimer, 2012). In 2003, Donald Berwick, proposed the model for use with physicians in
rural practices (Nagykaldi, Mold, Robinson, Niebauer, & Ford, 2006). In 2009, Kevin Grumbach
and James Mold, proposed a similar model be used to promote best practices in health care. By
2010, the Affordable Care Act authorized the formation of the Primary Care Extension Program
to develop models of practice coaching. Since then several large state-based studies conducted in
Oklahoma, Colorado, Oregon, and New York, have found the practice enhancement assistant
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model to be a cost effective means of improving patient care through enhanced systems and
adherence to best practices in primary care practices (Agency for Healthcare Research and
Quality, 2008, Bodenheimer, Wagner, & Grumbach, 2002). It was determined that the total
estimated savings from practice facilitation equaled approximately $2.8 million for the
Oklahoma Sonner Care Program (Telligen, 2012).
The most recent Institute of Medicine report supports the role of practice facilitator as an
example of the expanding role for nursing (Institute of Medicine of the National Academies,
2010). Dogherty, Harrison, & Graham (2010) found that facilitation is now being viewed as a
distinct role as well as a process. Basic activities of the role are to provide project management
and leadership, tailor activities to the local context, and link disease outcomes to medical and
nursing processes. (Dogherty et al, 2010). Sipila, Ketola, Tala, and Kumpusalo (2008) found
that facilitators did a better job of promoting multiprofessional teamwork. Stetler et al. (2006)
emphasized that facilitation is a deliberate process of interactive problem solving and support in
the context of a recognized need for improvement and supportive interpersonal relationships.
Nagykaldi et al. (2006) also found that facilitators were in a unique position to build
relationships, improve communication, and share resources within the practice seeking to
improve care.
The literature shows that the facilitator role is a distinct one with crucial behaviors and
activities. It is gratifying and affirming to read articles by several authors who propose that
nursing, especially advanced practice nursing, is in a unique and ideal position to serve as
practice facilitators (Doran & Sidani, 2007; Kirkman et al., 2001; Renders et al., 2001; Sipila et
al., 2008; Willens et al., 2011).
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Summary Recommendations
A review of the literature substantiates the need to improve the quality of care for persons
with diabetes and to work more closely with care providers to change the health care system to
better employ principles of comprehensive chronic disease management. Both providers and
recipients of care should remain the focus of positive change processes that incorporate
evidence-based guidelines to guide practice.
Practice facilitators appear to have a positive impact on implementing change within
practices, empowering providers to improve care delivery, and incorporating multiple systems
and disciples to sustain necessary change. The role of practice facilitation needs further research
as it has the potential of being a cost effective means to improve the quality of care across
disciplines while offering much needed support to overworked clinicians. Advanced practice
nurses are ideally poised and should be encouraged to equip themselves to move into such
positions of leadership. They can serve as facilitators to advocate for a positive change, improve
health care quality, and serve as a bridge to unite various disciplines and sectors in health
promotion activities for chronic disease.
There is clearly a need to continually review the components of evidence-based
guidelines as implemented in disease outcome measures, and question the choices made for
ongoing surveillance. Outcome measures should document monitoring and treatment for all the
significant complications of a disease and work to make the tracking of such complications more
feasible.
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Chapter 3
Method
The purpose of the project was to assist primary care providers through the use of a
practice facilitation model to improve the quality of diabetes care within their primary care
clinic. The specific aims include monitoring of the diabetes patient registry for outcome markers
to (a) improve HgbA1c to less than eight percent; (b) decrease low density lipoprotein
cholesterol to less than 100 mg/dl; (c) maintain blood pressure at or below 139/89; (d) decrease
tobacco nonuse; and (e) add daily aspirin for those with documented ischemic vascular disease.
This project used longitudinal, prospective, mixed methodology where quantitative
repeated measures were triangulated with qualitative data to provide a comprehensive
understanding of the diabetes outcomes.
Setting
This project took place in a small primary care clinic located in a suburban setting. The
clinic recently merged with a larger organization in the Midwest, United States. The larger
organization had a system in place for improving diabetes outcomes and in 2008 and 2011
received the Minnesota Bridges to Excellence award for superior patient care in diabetes
(Bridges to Excellence, 2011). The small clinic was given outcome goals to achieve within a
twelve month period, but little training or leadership in how to achieve the goals. In an attempt to
further incentivize the quality improvement efforts, the clinic manager was directed to post all
providers’ diabetes scores in the clinic break room on a monthly basis.
Sample
Six physicians and six clinical assistants, forming six provider teams (one physician
paired with one clinical assistant), participated in the project between January and April, 2012.
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Three physicians were board certified in internal medicine and three physicians were board
certified in family practice. The number of patients on each physician registry ranged from
sixteen to one hundred six with a total of three hundred sixty-six patients on all the diabetes
registries reviewed.
Ethical Considerations
Project participation was voluntary and participants were chosen on a first come first included
basis. Providers were informed verbally and in writing using informed consent about the purpose
and structure of the project. IRB approval was obtained from the organization and St Catherine
University. The study was initiated once participants agreed to participation for the entire four
month period. Confidentially was maintained throughout the project. No identifiable patient data
were used in the project and access to patient records was under strict Health Insurance
Portability and Accountability Act (HIPAA) guidelines. All meetings with providers and
provider teams were held in private, secure locations in the clinic. The content of each meeting
was not shared outside of the session and all recommendations developed as part of the project
were given exclusively to the provider teams. Participants were assured that no part of the project
interactions would be transmitted to clinic or health organization administration. It was
recognized that participants might feel uncomfortable about communicating their needs for better
diabetes patient management outcomes. However, this burden was no more than encountered
daily in routine clinic activities and surveillance.
Project data were stored in a locked cabinet in the facilitator’s office and was limited to
the facilitator, data analyst, and academic advisor. All data will be destroyed at the completion of
the academic program and presentation of study findings.
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Outcome Measures
Outcome measures used in the project were based on the Minnesota Community Measures and
accepted for use across the health care organization. Measures were:
•

HgbA1c less than 8%

•

Low density lipoprotein (LDL) cholesterol less than 100 mg/dl

•

Blood pressure at or below 139/89

•

Tobacco nonuse

•

Daily aspirin use for those with documented ischemic vascular disease

A composite measure of all five outcome measure was recorded in the diabetes registry on a
monthly basis for each provider. Calculation of the monthly composite measure was based on
Minnesota Community Measures guidelines, and accepted for use across the health care
organization.
Protocol
Six physicians in the adult medicine clinic of a primary care clinic in suburban Minnesota
were invited to participate in the project. The diabetes registry for each provider was used as the
basis for all interactions, and was initially reviewed to determine individual provider practice
patterns for diabetes management. Specific recommendations to improve diabetes outcome
scores that were not at target were developed by the practice facilitator who is a nurse
practitioner and diabetes specialist. Three interactive sessions were scheduled between the
practice facilitator and each provider or provider team. Providers were encouraged to include
their clinical assistants (physician-assistant provider teams) in the meetings as research has found
that auxiliary clinical personnel are important to successfully implementing and sustaining
practice change. The initial session was ninety minutes in length, the second session was thirty
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minutes, and the final session was via electronic mail, and scheduled for fifteen minutes.
Sessions occurred during regular clinic hours and time was blocked in each provider’s schedule
to allow for uninterrupted communication. Evidence-based, organizationally approved practice
guidelines for diabetes management were used to structure recommendations for care. Care goals
and specific interventions for improvement of each suboptimal outcome score were discussed
and recorded for future reference. System processes for ongoing disease management and patient
tracking utilizing the electronic medical record were reviewed with the provider team. At each
session the diabetes registry report, prescribed diabetes, lipid, and blood pressure medications,
lab orders, and results, vital signs, and any communication with the patient were reviewed.
Attention was directed to glycemic, lipid, and blood pressure control, and tobacco cessation as
appropriate. Aspirin use was reviewed for all diabetes patients with documented vascular
disease. At every session written recommendations were developed in collaboration with the
provider team. These recommendations served as a platform for practice changes over the
ensuing month and incorporated comments and suggestions from the provider team. Copies were
distributed to each person at the meeting but not shared with general clinic staff or
administration. Additional phone and electronic support and feedback were available to each
provider team between each session throughout the project. Follow-up sessions began with a
review of changes in the diabetes registry and clinical practice since the previous meeting.
Opportunity to discuss management or practice issues was planned for every session. The
practice facilitator and provider teams were employed by the health care system and covered by
HIPAA guidelines to access electronic medical records for patients on the diabetes registry. No
patient data were used for completion of the systems change project. Diabetes registry outcome
scores were used to assess changes in practice behaviors and disease management outcomes.
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Scores for four months before the project, four months during the project, and one month
following the project were used to establish a baseline for outcome measures and document
changes as a result of the intervention. Analysis of quantitative data from changes in outcome
scores was conducted at the conclusion of the project. Qualitative analysis of provider responses
to an open-ended question administered at the end of the project was also included.
Data Collection
The healthcare system diabetes outcomes registry was utilized throughout the systems
change project to track changes in percent outcome measures before, during, and for one month
after the project. The registry also served as a tool to target specific areas of diabetes
management that required provider team intervention. Data sets for the registry were established
and verified through Minnesota Community Measures, and were the same data sets utilized by
all the healthcare organizations in Minnesota currently participating in the state wide diabetes
quality improvement efforts. One stated advantage for using the established data sets for all
organizations was the ability to compare quality of diabetes care across all participating
healthcare organizations in the state. The Minnesota Department of Health promoted this
uniformity
Data Analysis Plan
Outcome measures for each provider from point zero to one month following the
intervention were included in the data analysis. Inclusion of data from the fifth month permitted
results from the third and final interaction to be assessed. The degree of change and number of
patients achieving optimal outcomes for each provider were determined using descriptive and
inferential statistics. Since the data were repetitious in nature, repeated analysis was performed to
prevent the compounding of error term. Data from the diabetes registry outcomes were used to
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assess whether the target 38% in outcome measurement was accomplished, and to what degree
improvement was achieved.
Both fixed-effects models and random-effects models were used to analyze the data. A
fixed-effects model assumes that the data being analyzed have the same quantitative effect and
that the differences observed are residual error. In the project, the five outcome measures (LDLcholesterol, blood pressure, HgbA1c, tobacco nonuse and aspirin use) and the composite
measure were considered fixed effects. However, each of the six providers responded differently
during the course of the project. The spread in the data were caused not only by the residual error
but also by between-provider differences. This type of situation required a random-effects model.
A random-effects model enabled the assessment of an entire sample of data for subgroup
differences without needing to split the data into subgroups and take into account the inherent
differences of individual providers and practice styles (Cleophas & Zwinderman, 2008; Riley,
Higgins, & Deeks, 2011).
Qualitative analysis of the open-ended question was done to look for theses related to the
second and third aims of the facilitation process. Individual provider response to the process was
also correlated to changes in outcome measures over the four months.
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Chapter 4
Results
The purpose of the project was to assist primary care providers to improve diabetes
quality of care within their primary care clinic. Project aims were to (a) improve diabetes
outcome measures to a target of 38% by the completion of the project; (b) increase providers’
knowledge and confidence in caring for their patients with diabetes; and (c) improve provider
team processes for the delivery of evidenced-based care to their patients with diabetes by more
consistent use of the diabetes registry data to individualize treatment plans.
Six providers from the medical clinic participated in the project. Data were derived from
the organizational diabetes registry for each provider. Diabetes outcome measures (percent LDL,
blood pressure, A1C, tobacco nonusage, aspirin use) and the monthly diabetes composite
measure of all five outcomes measures were averaged for each participant for four months prior
to the start of the project. The resulting average was used as a baseline. Diabetes outcomes
measures and composite measures were tracked for each of four months during the project.
Diabetes outcome measures and the composite measures were tracked for one month following
the project to capture improvements made during the last month of the project. Correlation
analyses and mixed model regression analyses were used to examine the data.
Aim 1: Improve diabetes composite scores to 38% by the end of the project.
Percent composite measures were reviewed at month five, and showed that two of six
participants achieved the goal of 38%. One participant achieved 38.0%, and a second achieved
41.7%. Remaining participants achieved composite measures ranging from 29.6% to 37.7% (see
Fig 1).
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Figure 1
Change in Composite Measures for Providers Before and After the Project
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1.) Multi-level Modeling
Each element of the composite measures was further examined using multi-levelmodeling. The reason for multi-level-modeling originated from the practice environment. Since
variation in care is, in part, related to individual providers, it is important to account for these
variations when changes in diabetes outcome measures are evaluated. All model fitting was done
using linear mixed-effects analysis. There was a positive change in each measure as the project
progressed.
a) Low density lipoprotein (LDL): The individual impact of this project can be seen in
the LDL measure. The goal for people with diabetes is to have an LDL outcome measure that is
less than 100 mg/dl. Table 1 clearly shows that patients’ LDL levels were decreased to a
significant level (p=0.0107) and this effect was moderately correlated with a change in the
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clinician’s management of diabetes (-0.397). A decrease in the LDL-cholesterol level is
anticipated to improve diabetes patient outcomes.
Table 1
Effects of Clinicians (random effects) on LDL (fixed effects)
Random Effects
Group Name

Variance

Intercept

4.176578

Std Dev

Correlation

-0.397

Monthly
3.168111

Residual
Fixed Effects
Group Name

Value

Std Error

t-value

p-value

Intercept

50.92778

1.945132

26.18217

0.000

Month

0.84333

0.309176

2.72768

0.017

b) Blood pressure (BP): Another diabetes outcome measure is the patients’ blood
pressure which is recorded at every visit to ensure that blood pressure is within a normal
range. The goal for blood pressure is at or below 139/89. The results indicate that the
intervention was not effective as the fixed effect (p=0.6085) was not significant (see Table
2). Blood pressure is affected by many factors such as blood pressure cuff size, the patient’s
position at the time of measurement, the length of time the patient was permitted to be in
a resting position prior to measurement, the mental state of the patient at the time of the
clinic visit, the skill of the person doing the measurement, etc. It is possible that other
contributing factors explain why the blood pressure was not improved significantly.
Although random effect (the clinicians’ effect) is explained by the correlation of -0.426, it is
not significant.
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Table 2
Effects of Clinicians (random effects) on Blood Pressure (fixed effects)
Random Effects
Group Name

Variance

Intercept

5.132988

Std Dev

Correlation

-0.426

Monthly
4.27367

Residual
Fixed Effects
Group Name

Value

Std Error

t-value

p-value

Intercept

83.06706

2.4465811

33.95230

0.0000

Month

0.21595

0.4170674

0.51779

0.6085

c) Glycosylated hemoglobin (Hgb A1c): Diabetes patients’ A1c were checked every 90
days to ensure that blood glucose was within a therapeutic range. The target for HgbA1c was less
than 8%. As illustrated in Table 3, the results indicate that the intervention was effective as the
fixed effect of the HgbA1c was significant (p=0.004). The random effect (clinicians’ effect) is
explained by the correlation of -0.344. This result means that the individual clinicians’ effects
were moderately correlated in decreasing the HgbA1c level. The negative sign is encouraging
and indicates that blood glucose levels were decreasing while patient outcomes were improving.
Table 3
Effects of Clinicians (random effects) on HgbA1c (fixed effect)
Random Effects
Group Name

Variance

Intercept

4.45655

Std Dev

-0.344

Monthly A1c
Residual

Correlation

2.82597
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Fixed Effects
Group Name

Value

Std Error

t-value

p-value

Intercept

75.50913

2.0018339

37.71998

0.000

Month

0.86357

0.2757865

3.13130

0.004

d) Tobacco Nonusage: The nicotine in tobacco is known to constrict blood vessels
through the body and contributes to further cardiovascular problems including high blood
pressure, heart attack, high cholesterol, and peripheral vascular disease (claudication). Smoking
also causes insulin resistance in both diabetic and nondiabetic people which further worsens
diabetes control, and contributes to the kidney disease, eye disease, and nerve disease seen in
diabetes. Smoking cessation is seen as essential to optimal health with diabetes. The results of
the study are very encouraging where the fixed effect of tobacco nonusage is significant
(p=0.0051); however, a low correlation exists (-0.139) for clinicans’ efforts that does not explain
this significant outcome (see Table 4). It is possible that knowledgeable clinicians were able to
energize their patients to change smoking behaviors.
Table 4
Effects of Clinicians (random effects) on Tobacco Nonusage (fixed effects)
Random Effects
Group Name

Variance

Intercept

5.52423

Std Dev

Correlation

-0.139

Monthly
1.301606

Residual

Fixed Effects
Group Name

Value

Std Error

t-value

p-value

Intercept

82.44742

2.2878133

36.03765

0.0000

Month

0.38464

0.1270237

3.02812

0.0051
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e) Aspirin (ASA) Use: The fifth outcome measure that is part of the composite score is the use

of aspirin. Emerging evidence supports the continuation of daily aspirin use (unless
contraindicated) for diabetes patients with known ischemic vascular disease and no longer
supports its use in diabetic patients ages 41 and older who have not yet developed ischemic
vascular disease. Ischemic vascular disease includes documented heart attack, stroke, and
atherosclerosis in any part of the body or blood clots in any arteries. Aspirin has been shown to
reduce the occurrence of further events in such individuals. The results (see Table 5) indicate that
a change in practice trended toward an improvement in aspirin use but was not significant
(p=0.2903). In addition, clinicians had a low correlation with this outcome (0.175). The
nonsignificant results may have been due to a lower number of patients with documented
ischemic vascular disease or the fact that some clinicians changed their practice to reflect the
current change in Minnesota Community Measures practice guidelines.
Table 5
Effects of Clinicians (random effects) on Aspirin Use (fixed effects)
Random Effects
Group Name

Variance

Intercept

7.569179

Std Dev

Correlation

-0.175

Monthly
2.268428

Residual
Fixed Effects
Group Name

Value

Std Error

t-value

p-value

Intercept

95.96210

3.1619579

30.348950

0.0000

Month

-0.23845

0.2213759

-1.077138

0.2903
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2) Overall Fixed Effects
When examining all five outcome measures without partitioning for random (clinician)
effect the only significant improvement noted was in glycosylated hemoglobin (HgbA1c).
Improvement in LDL cholesterol levels trended toward significant (see Table 6). This table
clearly outlines the importance of using multilevel modeling as random (clinician) effects are
submerged in the error term, making the results nonsignificant. The above noted tables provide
clarity into the role of clinicians on the diabetes outcome measures, and how they are correlated
with each individual marker.
Table 6
Paired Samples for Diabetes Outcome Measures
t

df

Sig (2-tailed)

Pair 1

Total-Total 2

-1.594

5

0.172

Pair 2

LDL-LDL2

-2.049

5

0.096

Pair 3

BP-BP2

-0.166

5

0.875

Pair 4

A1c-A1c2

-2.596

5

0.048

Pair 5

Tob-Tob2

-1.372

5

0.228

Pair 6

ASA-ASA2

0.747

5

0.489

3) Overall Clinician (random effects) on all outcomes
There was a significant improvement in percent total composite outcome measures for all
outcomes (see Table 7) from the beginning to the end of the project (p= 0.01). In addition, this
correlation is moderately strong (-0.491) and has contributed to improving patient outcomes.
This is reflected in Figure 2 which shows how the change in the composite scores improved.
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Table 7
Effects of Clinicians (random effects) on composite outcome measures
Random Effects
Group Name

Variance

Intercept

3.938193

Std Dev

Correlation

-0.491

Monthly
4.019775

Residual

Fixed Effects
Value

Std Error

t-value

p-value

Intercept

30.016667

1.9988907

15.016663

0.0000

Month

1.076667

0.3922898

2.744569

0.0103

Figure 2
Change in % Composite Outcome Measures

Note. Significance of change p = 0.01
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Aim 2: Increase in Providers’ Knowledge and Confidence
An open-ended question was administered to participants at the end of the project.
Responses were analyzed for themes. Four of the six providers found the experience to be
positive in terms of increasing their knowledge of diabetes management, improving diabetes
outcome scores, and increasing their skill in utilizing the diabetes registry. One provider felt the
project made little change in her care for patients with diabetes, but provided an opportunity to
review current clinical practice guidelines. This response was labeled as neutral. Another
provider did not feel the project was of any benefit to his practice and contributed no new
information about diabetes or the use of the diabetes registry. This response was labeled as
negative. Outcome and composite measures for all participating providers were compared
according to whether their responses were positive (blue line) or neutral/negative (red line).There
was a significant correlation between positive responses and improvement in percent composite
outcome measure (p= 0.0075) despite the fact that the providers with neutral/negative responses
started out higher than those providers with positive responses.
Figure 3
Clinician’s Attitudes and Composite Outcome Measures

Note. % Composite Measure, (p=.0075) red=negative attitudes,
blue=positive attitudes
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There was also a significant correlation between positive responses, and improvement in
percent LDL less than 100 mg/dl (p= 0.002) despite the fact that the providers with neutral or
negative responses started out higher in this variable as well.
Figure 4
Relationship between Attitude and LDL Outcome Measure

Note. % LDL >100 mg/dl, (p=.002) red=negative attitudes, blue=positive attitudes
Aim 3: Improve Health Team Processes
The final aim was to improve health team processes for the delivery of evidenced-based
care to their patients with diabetes by more consistent use of diabetes registry data.
Data from responses to the open-ended question were subjected to thematic content
analysis. Content was divided into four categories, changes in diabetes knowledge, use of the
organization’s diabetes systems, working with patients, and improved provider team relations.
Responses were coded for each category from which overarching themes were then identified.
Improvement in knowledge of diabetes and diabetes management. Five of six
providers noted some improvement in their knowledge of diabetes or diabetes related
management issues. Two providers reported improved knowledge of diabetes and cholesterol
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medications and one mentioned that the discussion of when to initiate insulin therapy was
helpful. Three providers found the incorporation of protocols for diabetes and cholesterol
management useful. Participants commented, “It was a help to work with you, especially to go
over the diabetes medication and when to start insulin,” and “I found the clinic protocols were
useful.”
Increased ability to work with the organization’s diabetes systems. The same five
providers expressed increased understanding of the various aspects of the diabetes management
systems currently in use by the organization. Four of the five specifically referenced improved
use of the diabetes registry and one mentioned increased use of the diabetes education support
systems. Participants reported, “I find it easier to track my diabetes patients and to use the
diabetes workbench on a regular basis,” and “I did not know about the diabetes education
program. I am sending some of my patients now.”
Working with their diabetes patients. Four of six providers felt the project improved
their ability to work with patients and/or improve outcome measures for their patients. They
expressed increased comfort with the visit process and more efficient use of their time which
produced a more relaxed encounter. Comments included, “I think my patients did benefit from
what I learned and my numbers got better,” and “[it was good to have]… time available to
discuss the more difficult patients with someone who knew more about diabetes.”
One provider felt the project was of no benefit to him and did not change the way he
practiced diabetes management. He felt he was already delivering good care and that some of his
patients were particularly hard to treat. “I take good care of my patients, but I cannot make them
do anything. They have to do that by themself …We should not be evaluated on what our
patients do.”
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Improved provider team processes. Four of the six providers felt the project improved
how they worked with their clinical assistants to care for their diabetes patients. Most felt there
was clarification of respective tasks and that the process of reviewing the reports each month was
becoming easier. Changes in treatment and follow-up of patients were improved. A participant
reported, “My nurse was able to help me more… I think we can work better to keep up every
month.” Some participants indicated, “It was a good opportunity to talk with my CNA so we
could develop a plan for how to better follow the patients,” and “My CNA was able to order lab
work and leave reminders for me about what the patient needed.”
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Chapter 5
Discussion
Diabetes is one of the most serious public health problems of the twenty-first century
(Albright, 2007; Glasgow et al., 1999; Meetoo, 2008). The rate of increase in the occurrence of
diabetes, and its complications has placed a tremendous burden on the American health care
system, and threatens to affect close to one third of the population in the next 30 years. Diabetes
complications markedly reduce the quality and length of life, and contribute to enormous health
care costs. Several large studies have shown that effective treatments and practices may
substantially reduce the impact of diabetes (Herman, 2007, ).
There has been significant progress in the last 15 years in the development of quality
measures for diabetes care. Most of diabetes care occurs at the primary care level (Willens et al.,
2011). This project was developed to pilot a facilitator model for system change using evidence
based quality measures to improve diabetes outcomes in a small primary care clinic. The project
aims were to a) improve diabetes outcome measures to a composite measure target of 38%; b)
increase providers’ knowledge and confidence in caring for their patients with diabetes; and c)
improve health team processes for the delivery of evidence based care and more consistent use of
registry data. Results indicated significant improvement in three of five diabetes outcome
measures, and a significant improvement in composite measures for diabetes management.
Quality Measures and Diabetes Care
Performance measures for diabetes have been in place since the late 1990s. There is
evidence that control of outcome measures such as LDL-cholesterol, blood pressure and HgbA1c
has a positive impact on reducing the severity and progression of diabetes complications. Trend
data in the last 20 years shows a reduction in death rates from hyperglycemia, hospital discharges
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for lower limb amputations, and the incidence of diabetes related end-stage renal disease
(Centers for Disease Control and Prevention, 2012). There is increasing evidence that
improvements in these quality measures translates into significant health care cost savings over
several years (Agency for Healthcare Research and Quality, 2008). The number of patients
covered by health plan and state surveillance systems for diabetes quality care has also increased
across a range of settings (Centers for Disease Control and Prevention, 2012). Improvement in
process measures for diabetes (eye exams, dental exams, foot exams, diabetes education
referrals, etc.) have been easier to maintain than improvement in outcome measures (Jamtvedt et
al., 2010; Landon et al., 2007). Unfortunately, improvements in process measures do not relate to
improvements in outcome measures (Mangione et al., 2006; Selby et al., 2007). Outcome
measures are directly associated with risk factors. Adequate control of risk factors is strongly
associated with improved clinical outcomes for cardiovascular disease, microvascular
complications, and mortality (Albright, 2010).
Pay for performance initiatives have been used in multiple systems in an attempt to
sustain positive quality changes. The effect of such initiatives remains controversial (Coleman &
Hamblin, 2007; O'Connor, 2012). Several studies show that improvements decreased after
incentives and feedback were removed, despite computer generated feedback support (O'Connor,
2012; Stolee et al., 2009). Incorporating a variety of quality improvement methods have
produced the greatest improvement in outcomes, but do not necessarily guarantee that such
improvements will continue over time.
From a provider perspective, the pay for performance system places a great deal of stress
on the care delivery end of the process. Diabetes care occurs predominately in the primary care
setting where providers are already challenged by heavy patient loads, understaffing, limited
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reimbursement and an shortened time-frame in which to meet with patients. There is insufficient
time allocated to help care providers understand the elements of quality improvement changes
that will impact their daily practice. Tying reimbursement to production can disproportionately
penalize those physicians who are working with underserved populations, low income groups or
those patients with a high level of socioeconomic disadvantage. Weak leadership can also
negatively impact how well providers do by not providing the support necessary to successfully
manage the many elements of chronic disease care or maintaining an environment where quality
of care is stressed.
In response to this added pressure, some providers have become adept at stacking their
patient panels in a favorable direction by limiting access to those who are less ill and those with
easier to manage chronic and acute illnesses. The variable income associated with pay for
production has resulted in many care providers moving from primary outpatient clinics to the
more predictable, salaried positions in specialty services or inpatient settings.
Improving the quality of care in diabetes and other chronic diseases is an important and
essential task. The impact of system changes on those providing care must be taken into account
and support systems developed and maintained to assist them on a daily basis. The facilitator
model offers just such a support, not only to improve quality of care, but also to sustain the
quality and provide much needed support to an overworked segment of the health care delivery
system.
Issues with Quality Measures
The use of dichotomized quality measures is easy to understand and report, but selection
of such measurement thresholds is challenging, subject to change, and does not allow for
individualization of care. Reporting dichotomous measures does not take into account
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improvements in measurement outcomes that have not been sufficient to achieve targeted levels,
but still have a potentially significant impact on disease outcomes. There is also the implication
that all patients above measurement targets need more aggressive management or additional
pharmacotherapy which increases the risk of overtreatment. The benefits of increased treatment
further diminish as patients approach the target measurement level while the risks of treatment
related side effects and the cost of treatment increases.
The exclusive use of outcome measures as a means of measuring quality of care does not
take into account the complexity of chronic disease management. Diabetes management covers
many behavioral, organizational, and clinical determinants that are not accounted for by
assessing outcome or composite measurements. There should be greater importance assigned to
defining and measuring the relationship between care givers and patients. The partnership
between patients, families, communities, and health care teams is a crucial component of care
management and the development of successful plans of care. This aspect of care is difficult to
assess and even harder to measure, but is an essential component of quality care.
Composite diabetes quality measures have been used as a means of improving the
reliability of performance measurement and ranking quality within and between health care
systems. Current composite scores tend to weigh each outcome measure equally which does not
take into account the clinical significance of individual measures. Because such scores reduce a
set of measures to a single dichotomous score for each patient there is a great deal of information
that is missing. This results in a lack of sensitivity for distinguishing between plans or physicians
and greatly reduces reliability (American Medical Association, 2010).
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Patient Reports and Quality Measures
Self-management education is an essential aspect of diabetes care and requires active
engagement on the part of patients and health care provider teams. Current quality measurement
systems do not include the collection of patient reported information. Such information has a
direct impact on the patient’s understanding of disease processes and treatments, adherence to
treatment plans, and disease outcomes. Patient reported information is essential to understanding
patient preferences, and goals, decision making practices, self-care behaviors, psychosocial
functioning, and risk factors, and patient-health system relations (Fox & Chesla, 2008). There is
a need to develop a standardized set of behavioral and psychosocial patient-reported measures
that can be incorporated into the electronic medical record and utilized as part of a more
comprehensive quality performance measurement system.
There is great need for a tool that will elicit information related to how patients perceive
their health and what their personal health goals may be. Providers need an opportunity to see
how the treatment plan is being incorporated into patients’ lives and what obstacles patients
encounter as they work to achieve personal health goals. Especially in chronic disease, there is
often a mismatch between patient expectations and those of health providers. This mismatch is
never clearly identified and significantly handicaps both parties as they try to interact. Behavioral
health has developed a simple, numbered scale to determine levels of depression. This tool is
clear, and easy enough for patients to complete in three minutes during a clinic encounter. Scores
from this scale are part of ongoing medical records and are currently used to measure response to
treatment. A similar tool to measure response to chronic disease management would be an
excellent way for patients and providers alike to determine progress toward individual health
care goals and satisfaction with how care is delivered. Current quality measures are lacking in
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this essential information. The current study did not assess patient self-reports. These data could
potentially differentiate between the effect of providers’ actions and the impact of patients’
responses, and offer concrete ways to further effect positive change.
Advanced Practice Nursing and Quality Measures
Nursing at all levels plays a pivotal role in transforming the health care system and
improving the quality of care. The Institute of Medicine report on the Future of Nursing (2010)
strongly supports both the expansion of the advanced practice nursing role and the need for
lifelong learning as an essential component of professional nursing. The role of practice
facilitator provides an excellent opportunity for advanced practice nursing, especially those at the
doctorate of nursing practice level, to expand the boundaries of practice, promote positive system
change, advance the quality of health care, and place both the patient and health care provider
team at the center of the change process. The multifaceted nature of practice facilitation requires
a level of knowledge management and brokering that is dependent on a broad perspective and
extensive experience in the health care system. Systems thinking and population management are
essential skills that are part of the unique training of the doctor of nursing practice prepared
advanced practice nurse. The ability to assess care processes, incorporate different sources of
information and research, evaluate clinical outcomes and perform impact evaluations are
necessary to achieving ongoing quality improvement. Intervention must be tailored to the unique
settings of each clinical practice or health care system. The doctor of nursing practice advanced
practice nurse is well placed as a clinical leader. Such a professional can promote evidence based
practice and support the full potential of a high quality health care delivery system.
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Limitations of the Project
The project showed a small, but significant improvement in outcome measures for LDLcholesterol, glycosylated hemoglobin, and tobacco nonuse, and a small, but significant
improvement in the composite measure for diabetes care. These results support findings from
published studies using similar practice facilitation approaches. Since this was a pilot study these
results should be interpreted with caution. The problem related to the small sample size of this
pilot is a serious challenge and was insufficient to provide statistical power for the project
question. Variation in delivery of facilitation services was unavoidable as the needs of different
providers and time constraints of the clinic setting dictated the content of each session. The
outcome measures and composite measures data used for analysis were accepted as both valid
and reliable as they derived from the organization’s diabetes registry. The outcomes data could
not be verified since data on the diabetes registry were obtained from the organization’s audits of
the electronic medical records and laboratory data and were not directly obtained in a controlled
setting for use in the project.
Four of the providers spoke English with a notable accent which potentially influenced
the level of provider-patient communication. Patient understanding of and response to, plans of
care are just as important as provider’s actions to improve outcomes. As previously mentioned,
several studies have identified the need for patient referenced feedback as an important
component of improving quality of care (de Belvis et al., 2009; O'Connor, 2012). The challenges
of communication issues between providers and patients could have contributed further to the
variation in provider practice.
The systems change project was a prospective, mixed methods design pilot study. The
intent was to integrate qualitative and quantitative data to better understand the impact and
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response to a major change in clinical practice. An assumption at the outset was that any
improvement in diabetes outcomes would have a greater likelihood of being sustained through
understanding the response of providers to the change process. Changes in practice that are
directed from the top down will be more likely to succeed if the change is tailored to the unique
setting of each clinic and clinician and the subjective response to the change is taken into
account. To this end, data were collected in a sequential manner with outcome and composite
measures tracked through the course of the project, analyzed, and then compared to qualitative
date from analysis of an open ended question at the end of the project. This approach was an
efficient way to collect data as responses to the open ended question took more time to collect
and analyze and would have added significantly to the complexity of the project if administered
concurrently. Adding the question at the end, allowed the clinicians to have more experience
working with a new system before giving a response. Unfortunately, sequential data collection
did not permit any adjustment in the facilitation process during the course of the intervention.
The short duration of the pilot and the lack of input from the clinical assistants further detracted
from the amount of improvement that could have potentially occurred and the richness of the
feedback obtained.
Recommendations
Practice Impact
The translation of research into practice through the use of evidence based guidelines is
an essential, yet complex process. There continues to be gaps that are not adequately addressed
by more conventional methods of continuing medical education, electronic alerts and reminder
systems or decision making tools for providers. Improved outcome measures in diabetes have
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had a positive impact on the quality of care and lead to a decrease in complications of diabetes.
Improved outcomes also lead to substantial cost savings.
The use of practice facilitation to promote quality improvement needs further exploration,
but appears to offer a creative means of enhancing the quality of patient care and offering
support to health care team members. A recent meta-analysis showed that primary care practices
were 2.76 times more likely to adopt evidence based guidelines through practice facilitation
(Baskerville et al., 2012). Practice facilitation incorporates a hands-on, individualized approach
that is seen as positive and enabling. Facilitation also brings multiple health team members
together with a common focus and system support that has the potential for successful and
sustained change and quality improvement.
Advanced practice nurses can play a critical role in facilitating evidence based practice.
Knowledge brokering is a key aspect of the advanced practice role which can be leveraged to
promote evidence based practice. Practice facilitation is an ideal opportunity for advanced
practice nurses to utilize the specific knowledge and skills that are unique to their training and
education.
Future Recommendations
Conceptual models for practice facilitation already exist (Dogherty et al., 2010; Fielden,
Davidson, and Sutherland, 2009; Gallagher-Ford, 2012; Group Health's MacColl Institute for
Healthcare Innovation et al., 2008). More large-scale, collaborative practice-based research is
needed to understand how facilitation can further support the adoption of evidence based
guidelines, the relationship between context and components of facilitation, sustainability, and
the costs to the healthcare system.
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As noted in Appendix A, the cost of implementing a practice facilitation project is
relatively low. This project budget was just over $13,000 which included temporary loss of
productivity for the provider teams’ participation in facilitation meetings. However, the return on
investment for 4 months of coaching was 260%. The high return came from potential cost
savings to the health plan from improved diabetes control. Improved control is expected to result
in fewer short term complications, fewer medical procedures and a decrease in hospitalizations
and emergency room visits for the one year period. Optimal diabetes control over a ten year
period for the same number of patients would yield a savings to the health care system of
$125,154.
As Appendix B identifies, there are many additional benefits of the practice facilitation
process that cannot be monetarily quantified. These benefits potentially improve efficiency and
job satisfaction for providers and customer satisfaction for recipients of care. An increase in the
retention of skilled health care professionals within a health system and more efficient patient
care delivery reduces operating costs and by association, health care costs substantially.
Finally, the use of random effects modeling provided a more sensitive means of
analyzing the influence of providers on changes in outcome measures. The more traditional form
of analysis in biomedical research is the fixed effects model. Fixed effects modeling is based on
averages and the assumption that a single true effect size underlies all study results (Polit &
Beck, 2008). With fixed effects modeling observed estimates are thought to vary only as a
function of chance. However, clinical outcomes are influenced by a variety of factors that must
be accounted for in explaining the results. A random effects model does a better job of allowing
for the influence of these factors on the outcome and permits the inclusion of potentially
important data in the final assessment. Fixed effect modeling runs the risk of oversimplification
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and the loss of important data. By controlling out context, fixed effect modeling effectively cuts
out much of what is going on clinically that should have great importance to the investigator and
reader alike. Random effect modeling is able to explain and reveal specific differences between
higher level entities (Bell & Jones, 2012) and is therefore a better choice for clinical research. As
demonstrated in this project, the influence of providers on outcome measures would have been
completely missed with just a fixed effects model. This is a lesson to keep in mind for all clinical
research.
Conclusion
Practice facilitation is a creative, cost effective way of improving the quality of patient
care in diabetes. A practice facilitation model recognizes and supports the essential role of
multidisciplinary health teams in collaboration with patients to advance health promotion to its
highest level. Practice facilitators are potentially in an ideal position to not only initiate quality
changes, but also sustain the improvements that occur. Nurses are in a unique position to
continue research on practice facilitation as they traditionally have a perspective that
contextualizes the patient experience and a record of working across disciplines to incorporate
individualized approaches that maximize health outcomes. Facilitation is a completely different
vehicle for spreading innovation and improving performance in primary care. There needs to be
more resources devoted to the training and deployment of practice facilitators. Advanced
practice nurses should position themselves at the front of this innovation, develop the skills and
expertise to serve as practice facilitators, and continue the research to develop and evaluate a
variety of models for practice facilitation. It is imperative to extend the work in practice
facilitation to incorporate quality care measures in both diabetes and cardiac disease in more
primary care outpatient settings.
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Appendix A
Return on Investment
Project Budget
Activity

Amount

Provider time x6

3 hours @ $150.00 x6

$2,700.00

Facilitator time (3 hours

24 hours @ $48.00

$1,152.00

Nursing time x6

3 hours @ $30.00 x6

$540.00

Lost productivity (includes

3 hours @ 150.00 each x6

$2,700.00

facilitator)

3 hours @ $80.00 x6

$1,440.00

9 lab tests @ $75 each x7

$4,725.00

meeting + 2 hour prep for ea of
6 providers)

Total

$13,257.00

Sidorov, et al. (2002) determined that comprehensive care for diabetes in a managed care
program resulted in per month claims of $394.62 for enrollees in the program versus per month
claims of $502.48 for those with diabetes not enrolled in the program. Utilizing these numbers
and adjusting for 2012 using a conversion factor of 1.275 (Oregon State University, 2012) the
claims for comprehensive care are $503 per month and the claims for status quo care are $640 or
a cost savings of $137 a month. Twenty-one additional patients achieved optimal diabetes
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outcome measures by the end of the 4 month period. This is a savings of $1,644 per patient per
year for those with optimal outcomes measures. Using just the 21 patients in the project, the
annual cost savings is $34,524. Annual return on investment for 4 months of practice facilitation
is 260%. If optimal control is maintained in just these 21 patients for a period of 10 years, the
cost savings in 2012 dollars, using a conversion factor of 1.115 (Oregon State University, 2012)
would be $125, 154.
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Appendix B
Benefits of Participation
•

Improved efficiency in diabetes management activities

•

Increased knowledge in diabetes management

•

Improved diabetes outcome scores

•

Enhanced understanding of health system goals

•

Improved health team interaction

•

Increased job satisfaction/retention

•

More efficient use of diabetes tests, treatments, and surveillance options
(including increased number of OP visits)

•

Decreased urgent care, emergency and hospital encounters

•

Decreased diabetes complications

•

Enhanced patient satisfaction

•

Increased opportunity for P4P and QI bonuses

•

Streamlined workflow and staff utilization

